Clinical Trials Directory

Trials / Completed

CompletedNCT02293824

Effect of Feedings on Caffeine in Premature Infants

Effect of Feedings on Caffeine Pharmacokinetics and Metabolism in Premature Infants

Status
Completed
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Duke University · Academic / Other
Sex
All
Age
15 Days
Healthy volunteers
Not accepted

Summary

Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffeine metabolism and pharmacokinetics (PK) in this population. This prospective, observational, open-label, opportunistic PK study will compare the population PK of caffeine between infants fed formula and infants fed exclusively breast milk; compare the activities of caffeine metabolizing enzymes between infants fed formula and infants fed exclusively breast milk; and determine the effect of hypoxia, hypotension, and infection on caffeine PK and metabolism in premature infants.

Detailed description

This study will use a consecutive patient sampling approach. All eligible participants admitted at each site will be approached. Caffeine and feedings will be administered per standard of care. Manipulations of caffeine dosing or feeding regimens will not be a part of this protocol. To minimize the amount of blood sampling, the investigators will use a sparse sampling methodology. Urine will be collected for analysis of caffeine and caffeine metabolite concentrations. Caffeine pharmacokinetics will be described by population pharmacokinetic analysis. Urinary concentrations of caffeine and its metabolites will be used to calculate metabolic ratios as markers of enzyme activity.

Conditions

Interventions

TypeNameDescription
DRUGCaffeineGiven per standard of care.

Timeline

Start date
2014-12-01
Primary completion
2017-06-30
Completion
2017-06-30
First posted
2014-11-18
Last updated
2017-09-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02293824. Inclusion in this directory is not an endorsement.